The Mumbai-based startup plans to use the fresh capital to expand its digital footprint and introduce newer categories in its portfolio of products Founded in 2021, Foxtale provides targeted skincare solutions to address a variety of skin concerns such as acne, ageing and hyperpigmentation among others The company claims to have clocked a gross merchandise value of INR 172 Cr in FY24 Direct-to-consumer (D2C) skincare startup Foxtale has secured $18 Mn (around INR 150 Cr) in its Series B funding round led by Singapore-based Panthera Growth Partners, with participation from existing backers Matrix Partners India and Kae Capital. The Mumbai-based startup plans to use the fresh capital to expand its digital footprint and introduce newer categories in its portfolio of products, founder and CEO Romita Mazumdar said. Founded in 2021, Foxtale provides targeted skincare solutions to address a variety of skin concerns such as acne, ageing and hyperpigmentation among others.
It sells a wide range of skincare products such as serums, masks, moisturisers, face washes, sunscreens, which are retailed on Foxtale’s website, online marketplaces and offline stores. Foxtale claims to cater to users across more than 100 cities across India, with its products accessible to women in the 23-35 age group in tier I, tier II and tier II cities. The startup claims to have clocked a gross merchandise value of INR 172 Cr in FY24 on the back of sales generated through its official website.
Furthermore, i.
